Jurisdiction - Hong Kong
Kirkland & Ellis Represents China Traditional Chinese Medicine In Its HKD 7.2bn Share Issuance.

2 April, 2015


Kirkland & Ellis is acting for Hong Kong-listed China Traditional Chinese Medicine Co. Limited  in its proposed issuance of new shares to its controlling shareholder and two executive directors, and its share placement to 25 professional and international institutional investors for a total amount of HKD 7.2bn (approx USD 930m).  The transaction was announced on 30 March 2015. 


The Kirkland team is led by Hong Kong-based corporate partners Frank Sun, Joey Chau and David Yun.


Conventus Law

Follow us on Twitter @conventuslaw

Comments are closed.